Company profile: Singular Genomics
1.1 - Company Overview
Company description
- Provider of genomic technologies built on the Singular Sequencing Engine, including the G4 benchtop sequencer for a wide range of genomic applications and flexible sample processing; the G4X spatial sequencing platform for multiomic analysis of FFPE samples at subcellular resolution; and consumables such as Max Read, F2/F3 kits, library compatibility kits, indices and adapters.
Products and services
- G4X: FFPE-optimized spatial sequencing platform enabling multiomic analysis at subcellular resolution, integrating high-throughput spatial sequencing for detailed characterization of FFPE samples
- Max Read Kits: High-throughput kits engineered for low-cost sequencing on the G4 platform, compatible with single cell and spatial gene expression applications
- G4: Industrial-grade benchtop sequencer engineered for a wide range of genomic applications, offering flexibility in sample processing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Singular Genomics
XyloCor Therapeutics
HQ: United States
Website
- Description: Provider of gene therapies for coronary artery disease: XC001 treats refractory angina by stimulating new coronary blood vessel formation; XC002 is in development to regenerate cardiac tissue in heart failure after past heart attacks by converting non-functioning cardiac cells into functioning ones.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XyloCor Therapeutics company profile →
Cobra Biologics
HQ: United Kingdom
Website
- Description: Provider of contract manufacturing for biologics and pharmaceuticals for pre-clinical, clinical, and commercial supply. An international CMO with three GMP-approved facilities in Sweden and the UK, offering expertise tailored to customers worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cobra Biologics company profile →
Interactive Biosoftware
HQ: France
Website
- Description: Provider of software solutions for clinical and research scientists in the human genetics field, focusing on practical software applications for health care and life sciences, particularly molecular biology, serving geneticists and researchers worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interactive Biosoftware company profile →
GeneTether
HQ: United States
Website
- Description: Provider of genome editing enhancement platforms that tether or conjugate donor DNA templates to editing complexes, including the GeneTether Platform and TNT technology to boost DNA insertion efficiency with targeted tools like CRISPR-Cas, and pursuing strategic partnerships in human therapeutics, animal health, agriculture, and cell delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneTether company profile →
Microarrays
HQ: United States
Website
- Description: Provider of microarray platforms and services for analyte testing, diagnostics, and personalized medicine, including pathway-focused gene expression arrays (MI PathArray), whole-genome microarrays (MI ReadyArray), DNA and protein/antibody arrays, assay development, and lab services for RNA profiling and microarray assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microarrays company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Singular Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Singular Genomics
2.2 - Growth funds investing in similar companies to Singular Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Singular Genomics
4.2 - Public trading comparable groups for Singular Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →